Canadian radioisotope developer MDS Nordion of Kanata, Ontario, said that it has made the isotope copper-64 (Cu-64) commercially available.
Cu-64 is principally used as a PET imaging isotope that provides physicians with higher resolution images, according to the company. Cu-64 is advantageous in that it has a half-life of 12.7 hours and can be distributed commercially, eliminating the need for users to have an onsite isotope production facility, MDS Nordion said.
In addition, the firm said that there is growing interest in the use of Cu-64 in molecular imaging and biodistribution studies as part of the drug development process, as well as possible therapeutic applications for the treatment of disease.
By AuntMinnie.com staff writers
June 16, 2005
Related Reading
MDS Nordion, Macrocyclics sign R&D accord, May 26, 2005
MDS hires Hawkins as chief science and technology officer, April 28, 2005
Declining U.S. dollar hurts MDS Life Sciences' Q1, March 11, 2005
MDS Nordion developing external-beam RT system, September 30, 2004
MDS Life Sciences shows Q3 revenue gain, September 9, 2004
Copyright © 2005 AuntMinnie.com
